For: | Simon I, Schaefer M, Reichert J, Stremmel W. Analysis of the human Atox 1 homologue in Wilson patients. World J Gastroenterol 2008; 14(15): 2383-2387 [PMID: 18416466 DOI: 10.3748/wjg.14.2383] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i15/2383.htm |
Number | Citing Articles |
1 |
A Zarina, I Tolmane, Z Krumina, AI Tutane, L Gailite. Association of variants in the CP, ATOX1 and COMMD1 genes with Wilson disease symptoms in Latvia. Balkan Journal of Medical Genetics 2019; 22(2): 37 doi: 10.2478/bjmg-2019-0023
|
2 |
Ana Sánchez-Monteagudo, Edna Ripollés, Marina Berenguer, Carmen Espinós. Wilson’s Disease: Facing the Challenge of Diagnosing a Rare Disease. Biomedicines 2021; 9(9): 1100 doi: 10.3390/biomedicines9091100
|
3 |
Stefanie D. Boyd, Morgan S. Ullrich, Amelie Skopp, Duane D. Winkler. Copper Sources for Sod1 Activation. Antioxidants 2020; 9(6): 500 doi: 10.3390/antiox9060500
|
4 |
Rosanna Squitti, Mariacarla Ventriglia, Massimo Gennarelli, Nicola A. Colabufo, Imane Ghafir El Idrissi, Serena Bucossi, Stefania Mariani, Mauro Rongioletti, Orazio Zanetti, Chiara Congiu, Paolo M. Rossini, Cristian Bonvicini. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency. Molecular Neurobiology 2017; 54(1): 671 doi: 10.1007/s12035-015-9664-6
|
5 |
Dorothy A. Kieffer, Valentina Medici. Wilson disease: At the crossroads between genetics and epigenetics—A review of the evidence. Liver Research 2017; 1(2): 121 doi: 10.1016/j.livres.2017.08.003
|
6 |
Magdalena Araya, Monica Andrews, Fernando Pizarro, Miguel Arredondo. Chaperones CCS, ATOX and COXIV responses to copper supplementation in healthy adults. BioMetals 2012; 25(2): 383 doi: 10.1007/s10534-011-9511-9
|
7 |
I. Zh. Zhalsanova, E. A. Fonova, D. I. Zhigalina, N. A. Skryabin. The ATOX1 Gene Role in Copper Metabolism and the Pathogenesis of Copper-Induced Diseases. Russian Journal of Genetics 2023; 59(3): 242 doi: 10.1134/S1022795423030122
|
8 |
Radan Bruha, Libor Vitek, Zdenek Marecek, Lenka Pospisilova, Sona Nevsimalova, Pavel Martasek, Jaromir Petrtyl, Petr Urbanek, Alena Jiraskova, Ivana Malikova, Martin Haluzik, Peter Ferenci. Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. Journal of Inherited Metabolic Disease 2012; 35(3): 541 doi: 10.1007/s10545-011-9422-5
|
9 |
Louis C. Penning, Marina Berenguer, Anna Czlonkowska, Kay L. Double, Petr Dusek, Carmen Espinós, Svetlana Lutsenko, Valentina Medici, Wiebke Papenthin, Wolfgang Stremmel, Jose Willemse, Ralf Weiskirchen. A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment. Biomedicines 2023; 11(2): 420 doi: 10.3390/biomedicines11020420
|
10 |
Ayca Cankorur-Cetinkaya, Serpil Eraslan, Betul Kirdar. Transcriptomic response of yeast cells to ATX1 deletion under different copper levels. BMC Genomics 2016; 17(1) doi: 10.1186/s12864-016-2771-6
|
11 |
Radan Bruha, Zdenek Marecek, Lenka Pospisilova, Sona Nevsimalova, Libor Vitek, Pavel Martasek, Jiri Nevoral, Jaromir Petrtyl, Petr Urbanek, Alena Jiraskova, Peter Ferenci. Long‐term follow‐up of Wilson Disease: natural history, treatment, mutations analysis and phenotypic correlation. Liver International 2011; 31(1): 83 doi: 10.1111/j.1478-3231.2010.02354.x
|
12 |
L. Králík, E. Flachsová, H. Hansíková, V. Saudek, J. Zeman, Pavel Martásek. Molecular Diagnostics of Copper-Transporting Protein Mutations Allows Early Onset Individual Therapy of Menkes Disease. Folia Biologica 2017; 63(5-6): 165 doi: 10.14712/fb2017063050165
|
13 |
I. Zh. Zhalsanova, E. A. Fonova, D. I. Zhigalina, N. A. Skryabin. The <i>ATOX1</i> Gene Role in Copper Metabolism and in the Copper-Induced Diseases Pathogenesis. Генетика 2023; 59(3): 283 doi: 10.31857/S0016675823030128
|
14 |
Tomasz Litwin, Anna Członkowska. Choroba Wilsona – czynniki wpływające na obraz kliniczny. Neurologia i Neurochirurgia Polska 2013; 47(2): 161 doi: 10.5114/ninp.2013.34397
|
15 |
Irene J. Chang, Si Houn Hahn. Wilson Disease. Handbook of Clinical Neurology 2017; 142: 19 doi: 10.1016/B978-0-444-63625-6.00003-3
|
16 |
Niti Kumari, Aman Kumar, Amit Pal, Babu Ram Thapa, Manish Modi, Rajendra Prasad. In-silico analysis of novel p.(Gly14Ser) variant of ATOX1 gene: plausible role in modulating ATOX1–ATP7B interaction. Molecular Biology Reports 2019; 46(3): 3307 doi: 10.1007/s11033-019-04791-x
|
17 |
Beom H. Lee, Joo H. Kim, Sun Y. Lee, Hye Y. Jin, Kwi-Joo Kim, Jin-Joo Lee, Jung-Young Park, Gu-Hwan Kim, Jin-Ho Choi, Kyung M. Kim, Han-Wook Yoo. Distinct clinical courses according to presenting phenotypes and their correlations to ATP7B mutations in a large Wilson's disease cohort. Liver International 2011; 31(6): 831 doi: 10.1111/j.1478-3231.2011.02503.x
|
18 |
Nivedita Singh, Pradeep Kallollimath, Mohd Hussain Shah, Saketh Kapoor, Vishwanath Kumble Bhat, Lakshminarayanapuram Gopal Viswanathan, Madhu Nagappa, Parayil S. Bindu, Arun B. Taly, Sanjib Sinha, Arun Kumar, Andreas R. Janecke. Genetic analysis of ATP7B in 102 south Indian families with Wilson disease. PLOS ONE 2019; 14(5): e0215779 doi: 10.1371/journal.pone.0215779
|
19 |
T. Litwin, G. Gromadzka, J. Samochowiec, A. Grzywacz, A. Członkowski, A. Członkowska. JIMD Reports - Case and Research Reports, 2012/5. JIMD Reports 2012; 8: 73 doi: 10.1007/8904_2012_163
|
20 |
Anna Członkowska, Tomasz Litwin, Petr Dusek, Peter Ferenci, Svetlana Lutsenko, Valentina Medici, Janusz K. Rybakowski, Karl Heinz Weiss, Michael L. Schilsky. Wilson disease. Nature Reviews Disease Primers 2018; 4(1) doi: 10.1038/s41572-018-0018-3
|
21 |
May T. Maung, Alyssa Carlson, Monserrat Olea‐Flores, Lobna Elkhadragy, Kyle M. Schachtschneider, Napoleon Navarro‐Tito, Teresita Padilla‐Benavides. The molecular and cellular basis of copper dysregulation and its relationship with human pathologies. The FASEB Journal 2021; 35(9) doi: 10.1096/fj.202100273RR
|
22 |
Relu Cocoş, Alina Şendroiu, Sorina Schipor, Laurenţiu Camil Bohîlţea, Ionuţ Şendroiu, Florina Raicu, Bart Dermaut. Genotype-Phenotype Correlations in a Mountain Population Community with High Prevalence of Wilson’s Disease: Genetic and Clinical Homogeneity. PLoS ONE 2014; 9(6): e98520 doi: 10.1371/journal.pone.0098520
|
23 |
Karolina Dzieżyc, Tomasz Litwin, Grzegorz Chabik, Karolina Gramza, Anna Członkowska. Families with Wilson's disease in subsequent generations: Clinical and genetic analysis. Movement Disorders 2014; 29(14): 1828 doi: 10.1002/mds.26057
|
24 |
Donghu Zhou, Siyu Jia, Liping Yi, Zhen Wu, Yi Song, Bei Zhang, Yanmeng Li, Xiaoxi Yang, Anjian Xu, Xiaojin Li, Wei Zhang, Weijia Duan, Zhenkun Li, Saiping Qi, Zhibin Chen, Qin Ouyang, Jidong Jia, Jian Huang, Xiaojuan Ou, Hong You. Identification of potential modifier genes in Chinese patients with Wilson disease. Metallomics 2022; 14(5) doi: 10.1093/mtomcs/mfac024
|
25 |
Grażyna Gromadzka, Magdalena Rudnicka, Grzegorz Chabik, Adam Przybyłkowski, Anna Członkowska. Genetic variability in the methylenetetrahydrofolate reductase gene (MTHFR) affects clinical expression of Wilson’s disease. Journal of Hepatology 2011; 55(4): 913 doi: 10.1016/j.jhep.2011.01.030
|
26 |
Richard Kirk. Clinical and Translational Perspectives on WILSON DISEASE. 2019; : 143 doi: 10.1016/B978-0-12-810532-0.00014-8
|
27 |
Xiaoyan Wu, Elise R. den Boer, Manon Vos-Loohuis, Frank G. van Steenbeek, Glen R. Monroe, Isaäc J. Nijman, Peter. A. J. Leegwater, Hille Fieten. Investigation of Genetic Modifiers of Copper Toxicosis in Labrador Retrievers. Life 2020; 10(11): 266 doi: 10.3390/life10110266
|
28 |
Elena Vasilievna Ovchinnikova, Mikhail Maksimovich Garbuz, Anna Aleksandrovna Ovchinnikova, Vadim Vladimirovich Kumeiko. Epidemiology of Wilson’s Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions. International Journal of Molecular Sciences 2024; 25(4): 2402 doi: 10.3390/ijms25042402
|
29 |
Karl Heinz Weiss, Wolfgang Stremmel. Evolving Perspectives in Wilson Disease: Diagnosis, Treatment and Monitoring. Current Gastroenterology Reports 2012; 14(1): 1 doi: 10.1007/s11894-011-0227-3
|
30 |
Muriel Bost, Guénaelle Piguet-Lacroix, François Parant, C.M.R. Wilson. Molecular analysis of Wilson patients: Direct sequencing and MLPA analysis in the ATP7B gene and Atox1 and COMMD1 gene analysis. Journal of Trace Elements in Medicine and Biology 2012; 26(2-3): 97 doi: 10.1016/j.jtemb.2012.04.024
|
31 |
Angela Sabalic, Veronica Mei, Giuliana Solinas, Roberto Madeddu. The Role of Copper in Alzheimer’s Disease Etiopathogenesis: An Updated Systematic Review. Toxics 2024; 12(10): 755 doi: 10.3390/toxics12100755
|
32 |
Valentina Medici, Karl-Heinz Weiss. Wilson Disease. Handbook of Clinical Neurology 2017; 142: 35 doi: 10.1016/B978-0-444-63625-6.00004-5
|
33 |
Petr Dusek, Daniela Zahorakova. Movement Disorder Genetics. 2015; : 293 doi: 10.1007/978-3-319-17223-1_14
|
34 |
Michelle Angela Camarata, Si Houn Hahn. Wilson Disease. 2019; : 105 doi: 10.1016/B978-0-12-811077-5.00009-8
|
35 |
Ronald Jan Corbee, Louis C. Penning. COMMD1 Exemplifies the Power of Inbred Dogs to Dissect Genetic Causes of Rare Copper-Related Disorders. Animals 2021; 11(3): 601 doi: 10.3390/ani11030601
|
36 |
S. Suresh Kumar, George Kurian, C. E. Eapen, Eve A. Roberts. Genetics of Wilson’s disease: a clinical perspective. Indian Journal of Gastroenterology 2012; 31(6): 285 doi: 10.1007/s12664-012-0237-6
|
37 |
A. E. Postrigan, I. Zh. Zhalsanova, E. A. Fonova, N. A. Skryabin. Modifier Genes as a Cause of Wilson–Konovalov Disease Clinical Polymorphism. Russian Journal of Genetics 2021; 57(5): 522 doi: 10.1134/S1022795421050094
|